Botanical species · safety record

Helichrysum arenarium

The EFSA Compendium of Botanicals holds 6 constituent measurements for Helichrysum arenarium. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Helichrysum arenarium (L.) Moench

6Constituent measurements
0Safety records
4Cited sources
3Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 3 licensed products naming Helichrysum arenarium as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Flower

What the records describe

Constituents measured

  • Scopoletin2
  • Arenarine c1
  • Esculetin1
  • Eugenol1
  • Umbelliferone1

Plant parts

  • Flower4
  • Unspecified2

Preparations

  • Solvent extraction4
  • Essential oil1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Arenarine cUnspecifiedNo resolvable identifier
EsculetinFlowerSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
EugenolUnspecifiedEssential oil1.8 PercentGC-MSNo resolvable identifier
ScopoletinFlowerSolvent extraction0.5 Milligram/kilogramFluorimetry, Nephelometry and PolarimetryNo resolvable identifier
ScopoletinFlowerSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
UmbelliferoneFlowerSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Haensel, R., Langhammer, L., Albrecht, A. G. Presence of scopoletin in the flower heads of Helichrysum arenarium. Scientia pharmaceutica, 1963, p. 88-94.
  2. Derkach, A. I., Komissarenko, N. F., Chernobai, V. T. Coumarins from inflorescences of Calendula officinalis and Helichrysum arenarium. Khimiya prirodnykh soedinenii, 1986.
  3. Lemberkovics, E., Czinner, E., Balazs, A., Bihatsi-Karsai, E., Vitanyi, G., Lelik, L., Bernath, J., Szoke, E. New data on composition of esssential oil from inflorescence of everlasting (Helichrysum arenarium(L.) Moench.) . . Acta pharmaceutica hungarica, 2001, vol. 71, no. 2, p. 187-91.
  4. Bel'tyukova, K. I. Effect of arenarine on phytopathogenic bacteria. Antibiotiki, akad. nauk ukr. s.s.r., inst. mikrobiol., 1958, p. 92-94.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue